BCV
NVO

Banque Cantonale Vaudoise’s Novo Nordisk NVO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45K Buy
30,296
+1,132
+4% +$48.6K ﹤0.01% 401
2026
Q1 		$1.07M Buy
29,164
+7,209
+33% +$342K 0.04% 365
2025
Q4 		$1.12M Buy
21,955
+1,971
+10% +$101K 0.04% 351
2025
Q3 		$1.11M Buy
19,984
+1,168
+6% +$68.4K 0.04% 345
2025
Q2 		$1.3M Buy
18,816
+4,241
+29% +$288K 0.05% 314
2025
Q1 		$1.01M Buy
+14,575
New +$1.2M 0.04% 352
2024
Q3 		$1.15M Sell
9,650
-173
-2% -$23.1K 0.05% 297
2024
Q2 		$1.4M Sell
9,823
-444
-4% -$58.8K 0.06% 288
2024
Q1 		$1.32M Buy
10,267
+9,603
+1,446% +$1.14M 0.05% 317
2023
Q4 		$69K Hold
664
– – ﹤0.01% 750
2023
Q3 		$60K Sell
664
-726
-52% -$64K ﹤0.01% 941
2023
Q2 		$113K Sell
1,390
-926
-40% -$75.6K 0.01% 838
2023
Q1 		$184K Sell
2,316
-1,284
-36% -$91K 0.01% 719
2022
Q4 		$243K Sell
3,600
-336
-9% -$19.7K 0.01% 661
2022
Q3 		$197K Buy
3,936
+412
+12% +$22.1K 0.01% 725
2022
Q2 		$197K Buy
3,524
+106
+3% +$5.88K 0.01% 741
2022
Q1 		$189K Sell
3,418
-1,352
-28% -$69.4K 0.01% 801
2021
Q4 		$267K Sell
4,770
-276
-5% -$15K 0.01% 759
2021
Q3 		$242K Sell
5,046
-264
-5% -$12.8K 0.01% 751
2021
Q2 		$222K Buy
+5,310
New +$206K 0.01% 821

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Banque Cantonale Vaudoise's NVO Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Novo Nordisk (NVO) stake by 3.9% in Q2 2026, buying an estimated $48.6K and bringing the position to 30,296 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

Banque Cantonale Vaudoise first reported a position in NVO in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.4M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Banque Cantonale Vaudoise held 30,296 shares of Novo Nordisk worth $1.45K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 1,132 Novo Nordisk shares in Q2 2026, an estimated $48.6K.
  • Novo Nordisk made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #401 holding.
  • Banque Cantonale Vaudoise first reported a position in Novo Nordisk in Q2 2021 and has held it in 20 quarters since.
  • Banque Cantonale Vaudoise's Novo Nordisk position peaked at $1.4M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.